Dyslipidemia
📧 Sign up to get email alerts when something new happens for Dyslipidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: Characterization of High Density Lipoprotein (HDL) in Type 2 Diabetes (T2D) After Fenofibrate or Niacin Treatment [Phase 4]
A completed Phase 4 study characterizing HDL properties in people with Type 2 Diabetes and dyslipidemia after treatment with fenofibrate or …
-
CLINICAL_TRIALS trial_result · 2014-05-19Clinical Trial Update: The Effect of XueZhiKang on Fatigue：Comparing With Simvastatin [Phase 4]
Phase 4 clinical trial comparing XueZhiKang with Simvastatin for fatigue in dyslipidemia; results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and Dyslipidemia [Phase 3]
Phase 3 trial evaluating the efficacy and safety of coadministered pitavastatin and valsartan in patients with hypertension and dyslipidemia…
-
CLINICAL_TRIALS trial_result · 2014-05-13Clinical Trial Update: Combined Behavioral and Pharmacological Intervention for Cardiovascular Risk Reduction in Diabetic Patients [NA]
Clinical trial update indicates the study on a combined behavioral and pharmacological approach to reduce cardiovascular risk in diabetic pa…
-
CLINICAL_TRIALS trial_result · 2014-05-06Clinical Trial Update: Regulation of Intestinal and Hepatic Lipoprotein Secretion by Resveratrol [Phase 2]
A Phase 2 trial assessed how resveratrol influences intestinal and hepatic lipoprotein secretion in individuals with dyslipidemia and insuli…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-04-29Clinical Trial Update: A 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected Subjects [Phase 4]
A 12-week Phase 4 trial comparing pitavastatin 4 mg versus pravastatin 40 mg in HIV-infected subjects with dyslipidemia; results have been p…
-
CLINICAL_TRIALS trial_result · 2014-04-16Clinical Trial Update: Strategies to Maintain Cardiac Risk Control After Discharge From Cardiovascular Risk Reduction Clinic [Phase 3]
A Phase 3 clinical trial evaluating strategies to sustain control of cardiac risk factors after discharge from a cardiovascular risk reducti…
-
CLINICAL_TRIALS trial_result · 2014-04-11Clinical Trial Update: Multi-Targeted Cardiac Risk Intervention in Type 2 Diabetes [Phase 3]
Phase 3 trial evaluating a multi-targeted cardiac risk intervention in type 2 diabetes has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-03-14Clinical Trial Update: Niacin/Laropiprant Tablet for South and Southeast Asians With Low High-Density Lipoprotein Cholesterol (LDL-C) at Risk for Cardiovascular Disease (MK-0524A-108) [Phase 3]
Phase 3 MK-0524A-108 trial evaluating a niacin/laropiprant tablet in South and Southeast Asians with low HDL cholesterol at risk for cardiov…
-
CLINICAL_TRIALS trial_result · 2014-02-28Clinical Trial Update: Dyslipidemia-related Risk Factors in Dialysis
Completed clinical trial assessing dyslipidemia-related risk factors in patients on dialysis.
-
CLINICAL_TRIALS trial_result · 2014-02-07Clinical Trial Update: A Study on Postmarketing Xuezhikang Capsule for Treating Dyslipidemia [Phase 4]
A Phase 4 postmarketing trial evaluating Xuezhikang Capsule for dyslipidemia has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-03Clinical Trial Update: An Open-Label Study of Vascazen in Cardiac Rehab Patients With Deficient Blood Omega-3 Fatty Acid Levels [Phase 2]
An open-label Phase 2 clinical trial evaluating Vascazen in cardiac rehab patients with deficient blood omega-3 fatty acid levels is being u…
-
CLINICAL_TRIALS trial_result · 2014-01-29Clinical Trial Update: Efficacy of a New Symbiotic Formulation in Children With Familial Hypercholesterolemia [Phase 1, Phase 2]
This trial update reports on the efficacy results from Phase 1/2 studies of a new symbiotic formulation in children with familial hyperchole…
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Study of Lipid Control in Hyperlipidemic Participants (MK-0653-179)
A completed clinical trial evaluating lipid control in hyperlipidemic participants.
-
CLINICAL_TRIALS trial_result · 2014-01-20Clinical Trial Update: Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood [Phase 3]
A Phase 3 clinical trial evaluating ABT-335 in combination with atorvastatin to assess vascular wall thickening in patients with abnormal li…
-
CLINICAL_TRIALS trial_result · 2014-01-14Clinical Trial Update: Study on the Efficacy aNd Safety of Jinlida Granules in Patients With Inadequately cOntrolled tYpe-2 Diabetes and dysLIpidemia Under liFe Style Intervention (ENJOY LIFE Study) [Phase 4]
Phase 4 trial evaluating the efficacy and safety of Jinlida Granules in adults with inadequately controlled type 2 diabetes mellitus and dys…
-
CLINICAL_TRIALS trial_result · 2014-01-14Clinical Trial Update: The Healthy Options Feasibility Study [NA]
The Healthy Options Feasibility Study conducted by McGill University has completed its trial evaluating the feasibility of healthy lifestyle…
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Efficacy Study of Diazoxide Choline to Treat Hypertriglyceridemia [Phase 2]
Phase 2 trial evaluating diazoxide choline for hypertriglyceridemia (a form of dyslipidemia) has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-07Clinical Trial Update: A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth
This citation notes the completion of a study evaluating physical and metabolic abnormalities in HIV-infected and uninfected children and yo…
-
EMA guidance · 2013-12-20Acipimox only to be used as additional or alternative treatment to reduce high triglyceride levels
The EMA announces that acipimox should be used only as an additional or alternative treatment to reduce high triglyceride levels, not as a f…
-
CLINICAL_TRIALS trial_result · 2013-12-17Clinical Trial Update: The Efficacy and Tolerability of Two Formulations of Atorvastatin In Korean Adult With Hypercholesterolemia [Phase 4]
Phase 4 trial comparing two formulations of atorvastatin in Korean adults with hypercholesterolemia showed data on efficacy and tolerability…
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Study of Cholesterol Levels and Types in African Americans With Type 2 Diabetes
A completed study evaluated cholesterol profiles, lipoprotein types, and apolipoprotein levels in African Americans with Type 2 Diabetes, wi…
-
CLINICAL_TRIALS trial_result · 2013-12-02Clinical Trial Update: Safety and Pharmacokinetis of TAP311 in Dyslipidemic Patients [Phase 1]
Phase 1 study reporting safety and pharmacokinetics of TAP311 in patients with dyslipidemia.
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Brazil Nut Consumption in Microvascular Endothelial Function, Oxidative Stress and Metabolic Abnormalities [NA]
This clinical trial investigates how Brazil nut consumption affects microvascular endothelial function, oxidative stress, and metabolic abno…
-
CLINICAL_TRIALS trial_result · 2013-11-13Clinical Trial Update: Resveratrol and Serum Apo A-I [NA]
A completed clinical trial from Maastricht University Medical Center evaluated resveratrol and its effect on serum apolipoprotein A-I in ind…